A pharmacologic basis for brain tumor chemotherapy.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D004317:Doxorubicin / Q000378:metabolism; D004347:Drug Interactions; D006801:Humans; D008055:Lipids; D008130:Lomustine / Q000378:metabolism; D008727:Methotrexate / Q000627:therapeutic use; D008862:Microsomes, Liver / Q000201:enzymology; D009362:Neoplasm Metastasis; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D010600:Pharmacology; D012995:Solubility; D014867:Water
D000970:Antineoplastic Agents; D008055:Lipids; D009607:Nitrosourea Compounds; D014867:Water; D008130:Lomustine; D004317:Doxorubicin; D008727:Methotrexate